551 results on '"Chen, Chiung-Tong"'
Search Results
52. Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies.
53. Click Chemistry and Multicomponent Reaction for Linker Diversification of Zinc Dipicolylamine-Based Drug Conjugates
54. Implanted islet mass influences the effects of dipeptidyl peptidase-IV inhibitor LAF237 on transplantation outcomes in diabetic mice
55. Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)
56. Immune response and pathophysiological features of Klebsiella pneumoniae liver abscesses in an animal model
57. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins
58. Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model
59. Engineering Nano‐ and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport
60. Peritoneal Effluent MicroRNA Profile in Encapsulating Peritoneal Sclerosis
61. Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
62. DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity
63. A Noninvasive Gut‐to‐Brain Oral Drug Delivery System for Treating Brain Tumors
64. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery
65. Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors
66. Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence
67. Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins
68. R432 is a key residue for the multiple functions of Ndt80p in Candida albicans
69. Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents
70. Shengmai San reduces hepatic lipids and lipid peroxidation in rats fed on a high-cholesterol diet
71. Enhanced oral bioavailability of paclitaxel by d-α-tocopheryl polyethylene glycol 400 succinate in mice
72. Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10)
73. Intravenous paclitaxel against metastasis of human gastric tumors of diffuse type
74. Human Breast Tumor Cells Express Multimodal Imaging Reporter Genes
75. BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy
76. Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives
77. Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas
78. Development and validation of a liquid chromatography–tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: Application to a pharmacokinetic study
79. A Natural Compound (Ginsenoside Re) Isolated from Panax ginseng as a Novel Angiogenic Agent for Tissue Regeneration
80. Molecular profiling of afatinib-resistant non-small cell lung cancer cells in vivo derived from mice
81. Paclitaxel-loaded poly( γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer
82. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes
83. BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities
84. Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
85. Abstract 1937: BPR6K609: An Aurora kinase inhibitor targeting small cell lung cancer with MYC amplification
86. Repurposing old drugs as antiviral agents for coronaviruses
87. Artificial intelligence approach fighting COVID-19 with repurposing drugs
88. Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System
89. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses
90. Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia
91. Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer
92. Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1
93. Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91
94. Impaired Phagocytosis of Capsular Serotypes K1 or K2 Klebsiella pneumoniae in Type 2 Diabetes Mellitus Patients with Poor Glycemic Control
95. Central pressor effects of CART peptides in anesthetized rats
96. A Dengue Virus Type 2 (DENV-2) NS4B-Interacting Host Factor, SERP1, Reduces DENV-2 Production by Suppressing Viral RNA Replication
97. Abstract 227: BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy
98. Abstract 4626: Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216
99. Linker Optimization and Therapeutic Evaluation of Phosphatidylserine-Targeting Zinc Dipicolylamine-based Drug Conjugates
100. Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.